Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia

被引:2
|
作者
Tan, Jian Hong [1 ]
Ahmad Azahari, Ahmad Hazim Syakir [1 ]
Ali, Adli [1 ,2 ]
Ismail, Noor Akmal Shareela [2 ,3 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Paediat, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, UKM Specialist Childrens Hosp, Hosp Tunku Ampuan Besar Tuanku Aishah Rohani, Res Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[3] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
关键词
autoimmune; epigenetic; blood disorder; DNA methylation; histone modification; lncRNA; miRNA; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; NONCODING RNA; T-CELL; DNA METHYLATION; IFN-GAMMA; HISTONE METHYLATION; BONE-MARROW; IMBALANCE; TH1;
D O I
10.3390/genes14030555
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Immune Thrombocytopenia (ITP) is an autoimmune blood disorder that involves multiple pathways responsible for the homeostasis of the immune system. Numerous pieces of literature have proposed the potential of immune-related genes as diagnostic and prognostic biomarkers, which mostly implicate the role of B cells and T cells in the pathogenesis of ITP. However, a more in-depth understanding is required of how these immune-related genes are regulated. Thus, this scoping review aims to collate evidence and further elucidate each possible epigenetics mechanism in the regulation of immunological pathways pertinent to the pathogenesis of ITP. This encompasses DNA methylation, histone modification, and non-coding RNA. A total of 41 studies were scrutinized to further clarify how each of the epigenetics mechanisms is related to the pathogenesis of ITP. Identifying epigenetics mechanisms will provide a new paradigm that may assist in the diagnosis and treatment of immune thrombocytopenia.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] EFFICACY OF SPLENECTOMY IN PRIMARY IMMUNE THROMBOCYTOPENIA
    Soboleva, O. A.
    Egorova, E. K.
    Pustovaya, E., I
    Sorkina, O. M.
    Sabirov, K. R.
    Gemdzhian, E. G.
    Prasolov, N., V
    Danishyan, K., I
    Melikyan, A. L.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 362 - 373
  • [22] Primary Immune Thrombocytopenia in Pregnancy Reply
    Bussel, James B.
    Hou, Ming
    Cines, Douglas B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18): : 1728 - 1728
  • [23] Advances in the pathophysiology of primary immune thrombocytopenia
    Perera, Maria
    Garrido, Teresa
    [J]. HEMATOLOGY, 2017, 22 (01) : 41 - 53
  • [24] Clonal hematopoiesis in primary immune thrombocytopenia
    Yanming Wang
    Tianshu Yu
    Qiaofeng Dong
    Shuang Liu
    Yafei Yu
    Hong Yu Zhao
    Ji Ma
    Lin Dong
    Liang Wang
    Daoxin Ma
    Yajing Zhao
    Yu Hou
    Xinguang Liu
    Jun Peng
    Ming Hou
    [J]. Blood Cancer Journal, 12
  • [25] The experience of Flebogammadif® in primary immune thrombocytopenia
    Julia, A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 12 - 15
  • [26] Treatment of primary and secondary immune thrombocytopenia
    Kado, Ruba
    McCune, W. Joseph
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 213 - 222
  • [27] Macrolide Treatment for Primary Immune Thrombocytopenia
    Ohe, Masashi
    Hashino, Satoshi
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (01): : 65 - 66
  • [28] Current treatment of primary immune thrombocytopenia
    Lozano, Maria L.
    Vicente, Vicente
    [J]. MEDICINA CLINICA, 2014, 142 (09): : 399 - 405
  • [29] Current Management of Primary Immune Thrombocytopenia
    Drew Provan
    Adrian C. Newland
    [J]. Advances in Therapy, 2015, 32 : 875 - 887
  • [30] Pathophysiology and management of primary immune thrombocytopenia
    Hirokazu Kashiwagi
    Yoshiaki Tomiyama
    [J]. International Journal of Hematology, 2013, 98 : 24 - 33